Letters
Drug pricing
Misconceptions about PPRS
BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39339.449641.3A (Published 20 September 2007) Cite this as: BMJ 2007;335:578- Aisling Burnand, chief executive
- BioIndustry Association, London SW1X 8PS
- kmurphy{at}bioindustry.org
Iheanacho argues that the Office of Fair Trading may have pinpointed some areas of improvement in the existing Pharmaceutical Price Regulation Scheme (PPRS).1 However, its proposals for introducing a value based system of drug pricing are inherently flawed and, if implemented, would lead to a significant erosion of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.